Relapse patterns and related prognostic factors in patients with mobile tongue cancer treated with postoperative radiotherapy

Journal of B.U.ON.

Volumn 14, Issue 1, 2009, Pages 51-56

  Kamer, Serra ^a   Esassolak, M ^a   Demirci, S ^a   Akyildiz, S ^a   Sengul, A ^a   Yavuzer, A ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Prognostic factors; Radiotherapy; Relapse patterns; Tongue cancer

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; DISEASE FREE SURVIVAL; ESOPHAGUS CANCER; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; SURVIVAL RATE; TONGUE CANCER; TREATMENT FAILURE; TUMOR LOCALIZATION;

ADULT; AGED; BONE NEOPLASMS; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TIME FACTORS; TONGUE NEOPLASMS; TREATMENT OUTCOME;

EID: 64249162388     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Zelefsky MJ, Harrison LB, Fass DE et al. Postoperative radiotherapy for oral cavity cancers: impact of anatomic subsite on treatment outcome. Head Neck 1990; 12: 470-475.
2. Korb LJ, Spaulding CA, Constable WC. The role of definitive radiation therapy in squamous cell carcinoma of the oral tongue. Cancer 1991; 67: 2733-2737.
3. Franceschi D, Gupta R, Spiro RH, Shah JP. Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg 1993; 166: 360-365.
4. Wendt CD, Peters LJ, Delclos L et al. Primary radiotherapy in the treatment of stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapy. Int J Radiat Oncol Biol Phys 1990; 18: 1287-1292.
5. El-Husseiny G, Kandil A, Jamshed A et al. Squamous cell carcinoma of the oral tongue: an analysis of prognostic factors. Br J Oral Maxillofac Surg 2000; 38: 193-199.
6. Kantola S, Parikka M, Jokinen K et al. Prognostic factors in tongue cancer - relative importance of demographic, clinical and histopathological factors. Br J Cancer 2000; 83: 614-619.
7. Al-Rajhi N, Khafaga Y, El-Husseiny J et al. Early stage carcinoma of oral tongue: prognostic factors for local control and survival. Oral Oncol 2000; 36: 508-514.
8. Fan KH, Lin CY, Kang CJ et al. Combined-modality treatment for advanced oral tongue squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2007; 67: 453-461.
9. Meoz RT, Fletcher GH, Lindberg RD. Anatomical coverage in elective irradiation of the neck for squamous cell carcinoma of the oral tongue. Int J Radiat Oncol Biol Phys 1982; 8: 1881-1885.
10. Sessions DG, Spector GJ, Lenox J, Haughey B, Chao C, Marks J. Analysis of treatment results for oral tongue cancer. Laryngoscope 2002; 112: 616-625.
11. Greenberg JS, Fowler R, Gomez J et al. Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer 2003; 15; 97: 1464-1470.
12. Friedlander PL, Schantz SP, Shana AR, Yu G, Shah JP. Squamous cell carcinoma of the tongue in young patients: A matched-pair analysis. Head Neck 1998; 20: 363-368.
13. Byers RM. Squamous cell carcinoma of the oral tongue in patients less than thirty years of age. Am J Surg 1975; 130: 475-478.
14. Sarkaria JN, Harari PM. Oral tongue cancer in young adults less than 40 years of age: Rationale for aggressive therapy. Head Neck 1994; 16: 107-111.
15. Siegelmann-Danieli N, Hanlon A, Ridge JA, Padmore R, Fein DA, Langer CJ. Oral tongue cancer in patients less than 45 years old: institutional experience and comparison with older patients. J Clin Oncol 1998; 16: 745-753.
16. Prosnitz RG, Yao B, Farrell CL, Clough R, Brizel DM. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2005; 61: 1087-1095.
17. Glaser CM, Millesi W, Kornek GV et al. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 2001; 50: 705-715.
18. Shintani S, Terakado N, Alcalde RE et al. The influence of blood arterial oxygen condition on the tumor response to preoperative radiation therapy in oral cancer patients. Oncol Rep 2001; 8: 99-102.
19. Bokemeyer C, Aapro MS, Courdi A et al. European Organisation for Research and Treatment of Cancer (EORTC) Task Force for the Elderly. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Eur J Cancer 2007; 43: 258-270.
20. Chao KS, Emami B, Akhileswaran R, Simpson J, Spector G, Sessions D. The impact of surgical margin status and use of an interstitial implant on T1, T2 oral tongue cancers after surgery. Int J Radiat Oncol Biol Phys 1996; 36: 1039-1043.
21. Yang K, Wen Y, Li L, Wang C, Wang T, Li W. Investigation of the tongue squamous cell carcinoma prognostic factors: Hua Xi Kou Qiang Yi Xue Za Zhi 2001; 19: 161-163.
22. Spiro RH, Guillamondegui O Jr, Paulino AF, Huvos AG. Pattern of invasion and margin assessment in patients with oral tongue cancer. Head Neck 1999; 21: 408-413.
23. Weijers M, Snow GB, Bezemer DP, van dr Wal JE, van der Waal I. The status of the deep surgical margins in tongue and floor of mouth squamous cell carcinoma and risk of local recurrence; an analysis of 68 patients. Int J Oral Maxillofac Surg 2004; 33: 146-149.
24. Lapeyre M, Hoffstetter S, Peiffert D et al. Postoperative brachytherapy alone for T1-2 NO squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins. Int J Radiat Oncol Biol Phys 2000; 48: 37-42.
25. Chen PH, Ko YC, Yang YH et al. Important prognostic factors of long-term oropharyngeal carcinoma survivors in Taiwan. Oral Oncol 2004; 40: 847-855.